.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Merck
Medtronic
Farmers Insurance
Daiichi Sankyo
US Army
Cerilliant
Colorcon
Teva
Johnson and Johnson

Generated: June 29, 2017

DrugPatentWatch Database Preview

TRI-LEGEST 21 Drug Profile

« Back to Dashboard

What is the patent landscape for Tri-legest 21, and what generic Tri-legest 21 alternatives are available?

Tri-legest 21 is a drug marketed by Barr and is included in one NDA.

The generic ingredient in TRI-LEGEST 21 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.

Summary for Tradename: TRI-LEGEST 21

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list1
Clinical Trials: see list99
Patent Applications: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRI-LEGEST 21 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr
TRI-LEGEST 21
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-21076405-001Oct 26, 2007RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Colorcon
Medtronic
Boehringer Ingelheim
Chinese Patent Office
UBS
AstraZeneca
McKesson
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot